Stressor specificity of peripheral catecholaminergic activation.
Kvetnanský
R
R
Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Pacák
K
K
Sabban
E L
EL
Kopin
I J
IJ
Goldstein
D S
DS
D015102:3,4-Dihydroxyphenylacetic Acid / Q000097:blood; D000818:Animals; D002395:Catecholamines / Q000097:blood*; D003080:Cold Temperature; D004295:Dihydroxyphenylalanine / Q000097:blood; D004837:Epinephrine / Q000097:blood; D004986:Ether; D006470:Hemorrhage / Q000503:physiopathology; D007003:Hypoglycemia / Q000503:physiopathology; D007328:Insulin; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood; D009638:Norepinephrine / Q000097:blood; D010146:Pain / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012149:Restraint, Physical; D013312:Stress, Physiological / Q000503:physiopathology*; D013315:Stress, Psychological / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D002395:Catecholamines; D007328:Insulin; D004986:Ether; D015102:3,4-Dihydroxyphenylacetic Acid; D008734:Methoxyhydroxyphenylglycol; D004295:Dihydroxyphenylalanine; C010117:3,4-dihydroxyphenylglycol; D009638:Norepinephrine; D004837:Epinephrine